Region ReGen Therapeutics Limited ('ReGen' or the 'Company') has today appointed MBM Partners to assist it in the development of a distribution network for its nutraceutical product Colostrinin in the countries of the Middle East and North Africa. ColostrininTM is marketed as a nutritional supplement to 'support healthy brain aging and cognition in humans' in several markets around the world including the USA, India, Turkey and Cyprus. ReGen are currently seeking licensees in other regions of the world...It represents a number of European companies in the distribution of their brands in the health and personal care sectors across the Middle East & North Africa region. The company works with the leading distributors in the region. These have been carefully selected for their expertise in the distribution of brands in this sector. MBM Partners aims to introduce the ColostrininTM opportunity to potential distributors and licensees in the region beginning with those in its current network. The initial focus will be to appoint distribution partners in the most important local markets...MBM Partners will be responsible for product registration and working closely with appointed distributors and licensees at both the strategic and operational level to ensure the success of the ColostrininTM brand. Commenting on this appointmentShilton, ReGen CEO said: This tie-up with MBM will hopefully lead to the distribution of Colostrinin within several markets in this currently untapped area. Working with a company that already has a network of established distributors and experience in getting products like Colostrinin marketed in the region should make this process more efficient'. To date ColostrininTM is marketed as a nutritional supplement to 'support healthy brain aging and cognition in humans' in the US, Canada, Australia, Poland, Cyprus, UK, Turkey and India. Kuwait, United Arab Emirates, Saudi Arabia, Oman, Bahrain, Qatar, Yemen, Iraq, Iran, Jordan, Syria, Lebanon, Egypt, Sudan, Tunisia, Libya, Algeria and Morocco ### Contact We're here to help.